Structured evidence table for Green Tea Extract Body Composition Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Green Tea Extract Body Composition Randomized Trial | The risk of NCDs such as diabetes and cardiovascular disease increases with aging due to a progressive decline in metabolic function [,]. | 2 | Fuke Saeka (2026) | Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial |
| Green Tea Extract Body Composition Randomized Trial | The World Health Organization identifies elevated blood glucose level and abnormal lipid profiles as key risk factors for NCDs []. | 2 | Fuke Saeka (2026) | Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial |
| Green Tea Extract Body Composition Randomized Trial | Moreover, in a previous study, acute intake of 1‐deoxynojirimycin from mulberry leaf extract reduced postprandial blood glucose level more effectively at dinner than at breakfast []. | 2 | Fuke Saeka (2026) | Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial |
| Green Tea Extract Body Composition Randomized Trial | 1 2 3 4 5 6 7 The global burden of noncommunicable diseases (NCDs) exceeded 43 million deaths in 2021, making them a major public health concern []. | 2 | Fuke Saeka (2026) | Effects of Green Tea–Intake Timing on Glucose and Lipid Metabolism in Older Adults: An 8‐Week Randomized Controlled Trial |
Source documents